NSE: BAYERCROP | BSE: 506285

Expensive Performer

Download real time

5079.80 39.10 (0.78%)

29.42% Fall from 52W High

36,393 NSE+BSE Volume

NSE 19 May, 2025 3:31 PM (IST)

22,829.7

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Bayer Cropscience Ltd. is on 26 May 2025 for the purpose of Audited Results & Final Dividend See details

Bayer Cropscience Ltd. share price target and research reports

Name: Latest research reports of Bayer Cropscience Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Bayer Cropscience Ltd.
Rating: 5
Author: Prabhudas Lilladhar

Latest analyst research reports with target prices and PDF download for BAYERCROP, BSE:506285 Bayer Cropscience Ltd.

Bayer Cropscience Ltd.

24 May 2020

5079.80

0.78%

Q4FY20 Result Update - COVID Shadow looms large; Reduce

Buy: Bayer Cropscience Ltd.

Target

Prabhudas Lilladhar

BYRCS reported solid results, topline grew by 82% YoY driven by high corn portfolio sales and sharp growth in CP segment. Massive sales return in 4QFY19 (57% revenue decline in 4QFY19 for core-BYRCS) led to favourable base but even excluding that growth is expected to be ~15-20% in CP. EBITDA (Rs582mn) and APAT (Rs601mn) reversed into profits from losses last year....

Bayer Cropscience Ltd. is trading below its 150 day SMA of 5401.9

Bayer Cropscience Ltd.

04 May 2020

5079.80

0.78%

Ashika - Stock Picks - Bayer CropScience Ltd. - May 2020

Buy: Bayer Cropscience Ltd.

Ashika Research

insecticides, fungicides and herbicides. The Company operates through Agri Care segment. It offers crop solutions for various crops, such as cotton, fruits, millet, mustard, pulses, rice, soybeans, sugar cane,...

Bayer Cropscience Ltd. is trading below its 150 day SMA of 5401.9

Bayer Cropscience Ltd.

12 Mar 2020

5079.80

0.78%

Monthly Update - Industry sales up 11% in February driven by +28% growth in NPKS sales

Buy: Bayer Cropscience Ltd.

Recommendation Target

Prabhudas Lilladhar

Total Industry volume is up 11% to 4.4 mn tons. Urea/NPK/DAP sales are @ 2.5 mn tons/0.8 mn tons/0.5 mn tons, up 3%/28%/26% resp. SSP volumes grew 10% to 0.3 mn tons. Domestic phosphatic fertiliser sales...

Number of FII/FPI investors decreased from 208 to 198 in Mar 2025 qtr

Bayer Cropscience Ltd.

23 Jul 2019

5079.80

0.78%

Q1FY20 Result Update

Hold: Bayer Cropscience Ltd.

Prabhudas Lilladhar

Bayer Cropscience (BYRCS) results were marred by late onset of monsoon and prolonged Kharif sowing leading to delay in product placement for the company. Results are significantly below our estimates and going forward the company may continue to report subdued performance if the rainfall does not pick up in South and West. Revenue/EBITDA declined 20% YoY to Rs6.6bn (PLe- Rs 8.7 bn)/ Rs1.2bn (Ple- Rs 2.0 bn) respectively while margins nosedived 900bps to 18.7%. For the long term, BYRCS continues to remain a compelling play given the group's global leadership in crop protection...

Number of FII/FPI investors decreased from 208 to 198 in Mar 2025 qtr

Bayer Cropscience Ltd.

31 May 2019

5079.80

0.78%

Q4FY19 Result Update

Hold: Bayer Cropscience Ltd.

Prabhudas Lilladhar

BYRCS reported disappointing 4Q results with high costs and decline in Change in Estimates | Target | Reco revenue of ~57% YoY (due high sales return) leading to EBITDA and PAT loss. Subdued market conditions led to sales return of placed stocks (even though...

Bayer Cropscience Ltd. is trading below its 150 day SMA of 5401.9

Bayer Cropscience Ltd.

05 Feb 2019

5079.80

0.78%

Bayer CropScience reported 29% yoy revenue growth to Rs6.2bn in Q3FY19, which was above o...

Sell: Bayer Cropscience Ltd.

Target

Emkay

Bayer CropScience reported 29% yoy revenue growth to Rs6.2bn in Q3FY19, which was above our and consensus estimates. Despite overall domestic remaining under stress the performance was driven by rice, fruits and vegetable segments. Gross margins improved by 130bps yoy to 42% owing to better product mix and inventory gains. EBITDA margin expanded 280bps yoy to 7.5% vs. our estimates of 5.7%....

Bayer Cropscience Ltd. is trading below its 150 day SMA of 5401.9

Bayer Cropscience Ltd.

23 Oct 2018

5079.80

0.78%

Bayer reported a revenue decline of 10% yoy to Rs11.0bn, which was well below our and con...

Sell: Bayer Cropscience Ltd.

Recommendation Target

Emkay

Bayer reported a revenue decline of 10% yoy to Rs11.0bn, which was well below our and consensus estimates, primarily due to adverse weather conditions in India (uneven rainfall and hailstorms) which affected standing crops, leading to down-trading by farmers. Despite this, gross margins improved by 170bps yoy to 39.9% on better product mix and inventory gains. However, EBITDA margins contracted by 350bps yoy due to a lower...

Number of FII/FPI investors decreased from 208 to 198 in Mar 2025 qtr

Bayer Cropscience Ltd.

09 Nov 2017

5079.80

0.78%

Bayer CropScience Ltd Q2FY18 results comment

Results Update: Bayer Cropscience Ltd.

HDFC Securities

Bayer CropScience Ltd Q2FY18 results comment Revenue grew by 76.5% to Rs. 1232.0 Cr in Q2FY18 when compared to the previous quarter. Also, it increased by 11.61% when compared with Q2FY17.

Bayer Cropscience Ltd. is trading above its 100 day SMA of 4973.6

Bayer Cropscience Ltd.

14 Aug 2017

5079.80

0.78%

Result Update - Bayer CropScience

Hold: Bayer Cropscience Ltd.

Axis Direct

Weak Q1 with revenue down by 15% (flat expected) and PAT at Rs 1.1 bn (Rs 1.4 bn expected). EBITDA margin plummeted to 16.6% (~23% in Q1FY17). The domestic business (~85% of revenue) was impacted by GST-led destocking, while international business was affected by weak global agrichem market.